It was confirmed that IFITM1 played a vital role in pancreatic cancer by analyzing the clinical and pathological characteristics of 90 patients with pancreatic cancer and their survival rate as well as by verifying through several bioinformatics online tools. This evidence concerns the gene IFITM1 and familial pancreatic carcinoma.